A Cost-Effectiveness Analysis of Nivolumab versus Docetaxel for Advanced Nonsquamous NSCLC Including PD-L1 Testing.
| Image |  |
|---|---|
| Description | scientific article published on 13 June 2016 |
| Author/s |
author: Stefan Aebi Klazien Matter-Walstra Matthias Schwenkglenks Dirk Klingbiel Oliver P Gautschi |
| Publication date | June 14, 2016 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |